Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Iovance Biotherapeutics Inc (IOVA)
Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,453,614
  • Shares Outstanding, K 255,918
  • Annual Sales, $ 0 K
  • Annual Income, $ -395,890 K
  • 60-Month Beta 0.11
  • Price/Sales 1,705.54
  • Price/Cash Flow N/A
  • Price/Book 2.10
Trade IOVA with:

Options Overview Details

View History
  • Implied Volatility 89.33% ( -3.77%)
  • Historical Volatility 92.42%
  • IV Percentile 53%
  • IV Rank 26.83%
  • IV High 163.67% on 09/14/23
  • IV Low 62.06% on 09/20/23
  • Put/Call Vol Ratio 0.06
  • Today's Volume 10,381
  • Volume Avg (30-Day) 4,107
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 216,800
  • Open Int (30-Day) 197,511

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.45
  • Number of Estimates 7
  • High Estimate -0.42
  • Low Estimate -0.47
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +29.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.53 +64.02%
on 10/31/23
5.95 -2.69%
on 11/24/23
+2.09 (+56.49%)
since 10/30/23
3-Month
3.21 +80.37%
on 10/19/23
6.47 -10.51%
on 09/12/23
-0.37 (-6.01%)
since 08/30/23
52-Week
3.21 +80.37%
on 10/19/23
9.36 -38.14%
on 05/23/23
-0.16 (-2.69%)
since 11/28/22

Most Recent Stories

More News
Why Iovance Biotherapeutics Stock Is Jumping Today

Another Wall Street analyst has jumped aboard the Iovance train.

GS : 340.26 (+0.77%)
IOVA : 5.79 (+1.94%)
Why Iovance Biotherapeutics Stock Is Marching Higher Today

Investors are excited by the prospects of a potential regulatory approval.

IOVA : 5.79 (+1.94%)
Iovance Biotherapeutics: Q3 Earnings Snapshot

Iovance Biotherapeutics: Q3 Earnings Snapshot

IOVA : 5.79 (+1.94%)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

DTC.CN : 2.7000 (-1.46%)
MGNX : 7.55 (+0.40%)
IOVA : 5.79 (+1.94%)
MRTX : 56.96 (+0.21%)
MRSN : 1.7500 (+10.06%)
DTCFF : 2.0700 (+3.50%)
LLY : 593.73 (+0.32%)
PFE : 30.17 (+0.30%)
Why Shares of Iovance Biotherapeutics Jumped Monday

The company's stock rally began on Friday.

IOVA : 5.79 (+1.94%)
MRK : 101.35 (+0.22%)
Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today

The approval process for the biotech's most advanced pipeline drug program is going quite well, it seems.

IOVA : 5.79 (+1.94%)
Stock Index Futures Slide as Investors Look Ahead to Fed Decision, UAW Walkout in Focus

September S&P 500 futures (ESU23) are down -0.14%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.28% this morning as investors watched for fallout from a strike initiated by the United Auto...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
MTCH : 33.00 (+1.60%)
NCLH : 14.98 (+1.01%)
HPQ : 29.28 (+0.72%)
HMB.S.DX : 169.540 (-3.16%)
F : 10.72 (+1.23%)
GM : 31.97 (+1.17%)
IOVA : 5.79 (+1.94%)
KEYS : 137.88 (+1.14%)
NUE : 164.00 (+0.13%)
KEY : 12.61 (+1.37%)
Why Shares of Iovance Biotherapeutics Dropped Thursday

The biotech stock's lead therapy is looking at some competition.

SGEN : 213.75 (+0.11%)
GMAB : 31.23 (-0.16%)
IOVA : 5.79 (+1.94%)
Iovance Biotherapeutics: Q2 Earnings Snapshot

Iovance Biotherapeutics: Q2 Earnings Snapshot

IOVA : 5.79 (+1.94%)
Why Iovance Biotherapeutics Stock Is Dropping Tuesday

The company is doing a $150 million public stock offering.

IOVA : 5.79 (+1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own...

See More

Key Turning Points

3rd Resistance Point 6.16
2nd Resistance Point 6.04
1st Resistance Point 5.86
Last Price 5.79
1st Support Level 5.55
2nd Support Level 5.43
3rd Support Level 5.25

See More

52-Week High 9.36
Fibonacci 61.8% 7.01
Fibonacci 50% 6.28
Last Price 5.79
Fibonacci 38.2% 5.56
52-Week Low 3.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar